Quality Assurance

Quality Assurance

Global Oversight , Regulatory Compliance , Inspection Readiness


Quality Assurance (QA) is at the core of successful clinical development. Our services provide end-to-end quality oversight across Phase I–IV trials and bioequivalence studies, ensuring compliance with ICH-GCP and the requirements of regulatory authorities worldwide.

Whether you are a sponsor, CRO, site, or vendor, we help you build confidence in your clinical programs by safeguarding data integrity, patient safety, and regulatory compliance.

Our Global QA Capabilities

  • Worldwide Coverage : QA support across North America, Europe, Asia-Pacific, and emerging markets.

  • Multi-Phase Expertise : From first-in-human studies through late-phase and post-marketing trials.

  • Regulatory Alignment : Deep understanding of FDA, EMA, MHRA, Health Canada, PMDA (Japan), TGA (Australia), and other health authorities.

  • Flexible Delivery : On-site, remote, or hybrid audits and inspections tailored to global study needs.

Our QA Service Portfolio

Risk-Based Auditing:

  • Sponsor systems and quality processes

  • Clinical trial sites (Phase I units, hospitals, specialty centers)

  • Bioequivalence and pharmacology study units

  • Central and specialty laboratories

  • Pharmacovigilance and safety reporting activities

  • Third-party vendors and CROs

  • Systemic gap assessments and root cause analysis

Trial Master File (TMF), Site & CRO Audits


  • eTMF and paper TMF compliance reviews

  • Phase I units and clinical site audits (screening, dosing, monitoring, data capture)

  • Vendor qualification and oversight audits

  • CRO process evaluations and GCP adherence checks

Mock Inspections & Inspection Readiness


  • Simulated regulatory inspections (FDA, EMA, MHRA, etc.)

  • Inspection readiness checklists, timelines, and gap closure plans

  • Staff training, role-specific coaching, and interview preparation

  • Documentation review and inspection war rooms (on-site/virtual)

SOP & Policy Development


  • SOP creation, review, and harmonization

  • Global regulatory alignment and best practices integration

  • Controlled document lifecycle management

  • Targeted SOP training for teams and vendors

Regulatory Inspection Support


  • On-site or virtual inspection support

  • Real-time stakeholder coordination and communication

  • Document retrieval and submission management

  • Query handling and immediate issue resolution

  • Post-inspection follow-up and strategy planning

Corrective and Preventive Action (CAPA) Management


  • Root cause analysis with industry-standard methodologies

  • CAPA plan development, tracking, and closure

  • Effectiveness checks and verification

  • Continuous process improvement

Why Partner With Us:

Comprehensive Global QA Coverage

Supporting Phase I–IV studies and bioequivalence programs worldwide

Regulatory Authority Expertise

Experienced in FDA, EMA, MHRA, PMDA, TGA, Health Canada, and local agency expectations.

Integrated QA Approach

From audits and inspection readiness to CAPA management, ensuring continuous compliance.

Scalable Engagements

Flexible models tailored to sponsors, CROs, sites, and vendors

Proven Success

A track record of helping clients achieve inspection readiness and maintain long-term compliance.